Non-insulino-dependant Diabetes in Infants and Teenagers (DIABIRUN)

November 23, 2021 updated by: Centre Hospitalier Universitaire de la Réunion

Evaluation of the Incidence of Diabetes Revealed at Pediatric Age in Reunion

The incidence of diabetes in children, which is constantly increasing worldwide is estimated in mainland France at about 15/100 000 per year with a wide disparity between countries and a north gradient South.

In Reunion island, about 30 children a year seem to reveal diabetes before the age of 18 years but no precise data has ever been published on this subject.

Indeed, while type 1 diabetes (insulin-dependent autoimmune) represents historically the majority of cases of diabetes revealed at pediatric age (about 90%), since a little more than 10 years other types of diabetes seem emerge at pediatric age. This is particularly the case of type 2 diabetes in connection with the global epidemic of obesity.

The purpose of the investigator's study is the exhaustive prospective collection of all cases of diabetes revealed before the age of 18 in the Reunion region over a period of 5 years.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Anticipated)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • France
      • Saint-Benoît, France
        • Recruiting
        • Groupe Hospitalier Est Réunion
        • Principal Investigator:
          • Yogananda THIRAPATHI, PH
      • Saint-Denis, France
        • Recruiting
        • Centre Hospitalier Universitaire Réunion
        • Principal Investigator:
          • Patricia PIGEON-KHERCHICHE, PH
      • Saint-Paul, France
        • Recruiting
        • Centre Hospitalier Ouest Réunion
        • Principal Investigator:
          • Karine BERNY-BURLOT, PH
      • Saint-Pierre, France
        • Recruiting
        • Centre Hospitalier Universitaire Réunion
        • Contact:
          • Lucie
        • Principal Investigator:
          • Laure HOUDON, PH

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

child or adolescent with diabetes

Description

Inclusion Criteria:

  • child or adolescent residing in the territory of the reunion island
  • with a diagnosis that revealed diabetes according to criteria defined by WHO (World Health Organization) before 18 years of age
  • Parents who signed the participation consent

Exclusion Criteria:

  • Patient not residing in the usual way in Reunion island

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Average annual number of new cases of diabetes according to World Health Organization (WHO) criteria
Time Frame: 5 years
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Centre Hospitalier Universitaire de la Réunion

Investigators

  • Principal Investigator: Laure HOUDON, MD, Centre hospitalier universitaire de la Réunion

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 24, 2020

Primary Completion (Anticipated)

January 1, 2025

Study Completion (Anticipated)

July 1, 2025

Study Registration Dates

First Submitted

November 5, 2019

First Submitted That Met QC Criteria

November 21, 2019

First Posted (Actual)

November 22, 2019

Study Record Updates

Last Update Posted (Actual)

November 24, 2021

Last Update Submitted That Met QC Criteria

November 23, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2014/CHU/10

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe